Growth Metrics

RedHill Biopharma (RDHL) Interest Coverage Ratio (2016 - 2023)

Historic Interest Coverage Ratio for RedHill Biopharma (RDHL) over the last 12 years, with Q2 2023 value amounting to 27.91.

  • RedHill Biopharma's Interest Coverage Ratio rose 118405.85% to 27.91 in Q2 2023 from the same period last year, while for Jun 2023 it was 1.2, marking a year-over-year increase of 8069.87%. This contributed to the annual value of 7107490.27 for FY2024, which is 54043268443.75% down from last year.
  • As of Q2 2023, RedHill Biopharma's Interest Coverage Ratio stood at 27.91, which was up 118405.85% from 69.07 recorded in Q1 2023.
  • In the past 5 years, RedHill Biopharma's Interest Coverage Ratio ranged from a high of 167.3 in Q2 2019 and a low of 69.07 during Q1 2023
  • Over the past 5 years, RedHill Biopharma's median Interest Coverage Ratio value was 4.29 (recorded in 2020), while the average stood at 15.0.
  • As far as peak fluctuations go, RedHill Biopharma's Interest Coverage Ratio surged by 290564.47% in 2019, and later plummeted by 172372.26% in 2023.
  • Over the past 5 years, RedHill Biopharma's Interest Coverage Ratio (Quarter) stood at 62.91 in 2019, then crashed by 93.12% to 4.33 in 2020, then plummeted by 987.5% to 38.41 in 2021, then grew by 20.52% to 30.53 in 2022, then skyrocketed by 191.42% to 27.91 in 2023.
  • Its Interest Coverage Ratio stands at 27.91 for Q2 2023, versus 69.07 for Q1 2023 and 30.53 for Q4 2022.